Figure 6. Transplantation of Erk1^−/− bone marrow increases BMD in WT recipients.

Six months after transplantation with WT, Erk1^−/− or Erk2^−/−BMMNCs into WT recipient mice, BMD was measured (N = 5 mice in each group). **P<0.05 for Erk1^−/− vs. WT recipients, as analyzed by ANOVA followed with post-hoc t-tests.